PRLD - Prelude Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRLD is currently covered by 2 analysts with an average price target of $2.58. This is a potential upside of $0.99 (62.26%) from yesterday's end of day stock price of $1.59.

Prelude Therapeutics 's activity chart (see below) currently has 45 price targets and 39 ratings on display. The stock rating distribution of PRLD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.86% with an average time for these price targets to be met of 58.8 days.

Highest price target for PRLD is $5, Lowest price target is $3, average price target is $4.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 22-Sep-2025. First documented stock forecast 19-Oct-2020.

Best performing analysts who are covering PRLD - Prelude Therapeutics :

Tazeen Ahmad Robert Burns Jeffrey Hung Peter Lawson Reni Benjamin

Currently out of the existing stock ratings of PRLD, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$5

$3.38 (208.64%)

1 months 10 days ago
(22-Sep-2025)

5/14 (35.71%)

$3.97 (385.44%)

100

Buy

$3

$1.38 (85.19%)

$4

2 months 15 days ago
(17-Aug-2025)

0/5 (0%)

$2.06 (219.15%)

Sell

$1

$-0.62 (-38.27%)

$5

1 years 5 days ago
(27-Oct-2024)

2/5 (40%)

$-0.5 (-33.33%)

136

Sell

$4

$2.38 (146.91%)

$10

1 years 10 months 14 days ago
(18-Dec-2023)

2/7 (28.57%)

$-0.04 (-0.99%)

4

Hold

$6

$4.38 (270.37%)

$10

2 years 11 months 12 days ago
(20-Nov-2022)

3/5 (60%)

$-0.53 (-8.12%)

54

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRLD (Prelude Therapeutics ) average time for price targets to be met?

On average it took 58.8 days on average for the stock forecasts to be realized with a an average price target met ratio 32.86

Which analyst has the current highest performing score on PRLD (Prelude Therapeutics ) with a proven track record?

TAZEEN AHMAD

Which analyst has the current lower performing score on PRLD (Prelude Therapeutics ) with a proven track record?

RENI BENJAMIN

Which analyst has the most public recommendations on PRLD (Prelude Therapeutics )?

Tazeen Ahmad works at BAML and has 3 price targets and 2 ratings on PRLD

Which analyst is the currently most bullish on PRLD (Prelude Therapeutics )?

Tazeen Ahmad with highest potential upside - $4.38

Which analyst is the currently most reserved on PRLD (Prelude Therapeutics )?

Peter Lawson with lowest potential downside - -$0.62

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?